ECYT : Summary for Endocyte, Inc. - Yahoo Finance

U.S. Markets closed

Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.07-0.02 (-0.96%)
At close: 4:00PM EST
People also watch
ACRXINFIEPZMCCXIMACK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.09
Open2.11
Bid1.54 x 100
Ask2.09 x 5100
Day's Range2.04 - 2.11
52 Week Range1.98 - 4.33
Volume85,958
Avg. Volume217,586
Market Cap87.49M
Beta1.50
PE Ratio (TTM)-2.05
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?
    Zacks2 hours ago

    Endocyte (ECYT) to Post Q4 Earnings: What's in the Cards?

    Endocyte, Inc (ECYT) is expected to report fourth-quarter 2016 results on Mar 1. The company has an impressive track record, having beaten estimates on three of the trailing four quarters and reporting in-line results in the remaining quarter

  • Valeant Streamlines Portfolio with Skincare Brands Sale
    Zackslast month

    Valeant Streamlines Portfolio with Skincare Brands Sale

    Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Or??al for $1.3 billion in cash.

  • Valeant to Sell Dendreon Unit to Sanpower for $820 Million
    Zackslast month

    Valeant to Sell Dendreon Unit to Sanpower for $820 Million

    Beleaguered Valeant Pharmaceuticals International, Inc. (VRX) announced that it will sell all the outstanding equity interests in Dendreon Pharmaceuticals, Inc. to the China based Sanpower Group Co., Ltd.